Education
About Us
Working with TipRanks
Follow Us
Tetra Bio-Pharma Inc (TSE:TBP)
TSX:TBP
Total Valuation
Tetra Bio-Pharma has a market cap or net worth of C$8.47M. The enterprise value is ―.
Market CapC$8.47M
Enterprise Value―
Share Statistics
Tetra Bio-Pharma has 423,362,730 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding423,362,730
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Tetra Bio-Pharma’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.58M
Employee Count33
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Tetra Bio-Pharma is ―. Tetra Bio-Pharma’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Tetra Bio-Pharma had revenue of 0.00 and earned -53.42M in profits. Earnings per share was -0.12.
Revenue0.00
Gross Profit0.00
Operating Income-24.84M
Pretax Income-52.18M
Net Income-53.42M
EBITDA-24.73M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -8.18M and capital expenditures -30.75K, giving a free cash flow of -8.22M billion.
Operating Cash Flow-8.18M
Free Cash Flow-8.22M
Free Cash Flow per Share-0.02
Dividends & Yields
Tetra Bio-Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Tetra Bio-Pharma upcoming earnings date is Apr 1, 2024, TBA Not Confirmed.
Last Earnings DateOct 19, 2023
Next Earnings DateApr 1, 2024
Ex-Dividend Date―
Financial Position
Tetra Bio-Pharma as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Tetra Bio-Pharma has paid 1.24M in taxes.
Income Tax1.24M
Effective Tax Rate―
Enterprise Valuation
Tetra Bio-Pharma EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Tetra Bio-Pharma has C$483.20K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$1.18M billion.
Cash & Marketable SecuritiesC$483.20K
Total DebtC$0.00
Net CashC$1.18M
Net Cash Per Share<C$0.01
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Tetra Bio-Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―